InvestorsHub Logo
Followers 51
Posts 3973
Boards Moderated 0
Alias Born 03/20/2014

Re: None

Wednesday, 01/24/2024 8:34:14 AM

Wednesday, January 24, 2024 8:34:14 AM

Post# of 465090
Concerned about Anavex efficacy for Rett?

Randi J. Hagerman, M.D.
January 12, 2021 | 11:30-12:45p.m.

The need for treatments that improve mitochondrial function, such as Anavex 2-73 can make a difference for both neurodevelopmental disorders and neurodegenerative disorders including Rett syndrome, FXS, Parkinson Disease, Alzheimer Disease and FXTAS. Future new treatments for FXSD will be reviewed including genetic interventions.

https://health.ucdavis.edu/mindinstitute/videos/images/dls/hagerman-2021-dls.pdf

All my posts are my opinion only and shouldn’t be used for decisions regarding purchasing or selling.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News